A019170 Stock Overview
Manufactures and sells pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Shinpoong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,550.00 |
| 52 Week High | ₩19,850.00 |
| 52 Week Low | ₩9,560.00 |
| Beta | 0.86 |
| 11 Month Change | -29.89% |
| 3 Month Change | 5.91% |
| 1 Year Change | -25.03% |
| 33 Year Change | -81.43% |
| 5 Year Change | 104.40% |
| Change since IPO | 560.38% |
Recent News & Updates
Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Sep 11
Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?
Aug 08Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 24Recent updates
Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Sep 11Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?
Aug 08Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 24Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?
Mar 07Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?
Feb 01
We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide
Jan 05Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?
Dec 10Shareholder Returns
| A019170 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.1% | -7.1% | -5.7% |
| 1Y | -25.0% | 6.6% | -3.9% |
Return vs Industry: A019170 underperformed the KR Pharmaceuticals industry which returned 6.6% over the past year.
Return vs Market: A019170 underperformed the KR Market which returned -3.9% over the past year.
Price Volatility
| A019170 volatility | |
|---|---|
| A019170 Average Weekly Movement | 12.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A019170's share price has been volatile over the past 3 months.
Volatility Over Time: A019170's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 828 | Jei-Man Ryu | shinpoong.co.kr |
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products.
Shinpoong Pharmaceutical Co.,Ltd Fundamentals Summary
| A019170 fundamental statistics | |
|---|---|
| Market cap | ₩644.19b |
| Earnings (TTM) | -₩41.63b |
| Revenue (TTM) | ₩208.78b |
3.1x
P/S Ratio-15.5x
P/E RatioIs A019170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A019170 income statement (TTM) | |
|---|---|
| Revenue | ₩208.78b |
| Cost of Revenue | ₩129.35b |
| Gross Profit | ₩79.43b |
| Other Expenses | ₩121.06b |
| Earnings | -₩41.63b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -812.13 |
| Gross Margin | 38.05% |
| Net Profit Margin | -19.94% |
| Debt/Equity Ratio | 16.4% |
How did A019170 perform over the long term?
See historical performance and comparison